Krystal Biotech Q2 profit climbs to $54.77 million

RTTNews··Read original
2▲1 ▼0Impact / 5
Summary · why it matters

Krystal Biotech reported higher second-quarter earnings, with net income rising to $54.77 million, or $1.79 per share, from $38.33 million, or $1.29 per share, in the same period last year. Revenue increased 24.1% to $119.22 million from $96.04 million a year earlier.

Impact on assets 1

Biotech & Genomic Medicine▲
Krystal Biotech Inc
KRYS
▲ PositiveCapitalrelevance

Q2 net income and revenue rose strongly, beating prior-year results.